ASH 2022 Conference Coverage
Playback speed
10 seconds
ASH 2022 Ponatinib & Blinatumomab for Patients With R/R Ph+ ALL or CML in Lymphoid Blast Phase: Subgroup Analysis From a Phase II Study
By
ASH 2022 Conference Coverage
FEATURING
Walid Macaron
By
ASH 2022 Conference Coverage
FEATURING
Walid Macaron
60 views
February 7, 2023
Login to view comments.
Click here to Login
Leukemia